KIORA PHARMACEUTICALS INC
For the period ended Jun 30, 2025. Filed Aug 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 8, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
No officers or directors, as defined in Rule 16a-1(f), adopted, modified orterminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement as defined in item 408 of Regulation S-K, during the period ended June 30, 2025.
In May 2025, we terminated our Employee Stock Purchase Plan (the "ESPP") effective as of April 30, 2025. We provided notice of the ESPP's termination to our employees and ESPP participants, and there are no employee funds currently held for purchasing shares of Common Stock under the ESPP.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.